Media
Media
Our latest announcements
Hansa Biopharma participating in Pareto Securities’ 17th Annual Healthcare Conference 2026
27/08/2026
Notice to Extraordinary General Meeting in Hansa Biopharma AB (publ)
Regulatory press release
21/08/2026
Hansa Biopharma Announces Confidential Submission of Draft Registration Statement to the SEC to allow for a potential Listing of ADSs in the United States
Regulatory press release
21/08/2026
Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
18/08/2026
Media articles
Insights
The Power of Hope: Redefining Treatment Decisions for Highly Sensitized Kidney Patients
07/08/2025
Fueling the future: the role of biotech in advancing innovative science and delivering new medicines
02/05/2024
Addressing barriers to gene therapy treatment
31/01/2024
Acknowledging Disparities Between Sexes in Kidney Transplantation
09/03/2023
Patients' perspective
Life on tour with chronic kidney disease
“I had always played the guitar and wrote songs but never really did anything with it. Nothing was going to hold me back now! No more excuses… there wasn’t time!”
Patients' perspective
Suspended time: a journey from diagnosis to transplant
"Dialysis may sound simple, but it isn’t, and over the course of his treatment Ron underwent several different kinds, all of which made him feel awful."
